Dr. Lalita Shevde-Samant, associate professor at the University of Alabama at Birmingham’s Division of Molecular and Cellular Pathology and a scientist at the UAB Comprehensive Cancer Center, was recently elected a member of the Chemo/Dietary Prevention Study Section for the Center for Scientific Review of the National Institutes of Health.
Shevde-Samant was selected on the basis of her demonstrated competence and achievement in her scientific discipline.
In her new role, the Indian American researcher will review grant applications submitted to the NCI, make recommendations and survey the status of research in applicants’ fields of science.
Shevde-Samant’s research at UAB focuses on defining mechanisms that regulate tumor progression and metastasis, applying this knowledge to complement and extend current clinical applications and provide additional therapeutic strategies.
Shevde-Samant graduated from the Cancer Research Institute, University of Mumbai and completed her postdoctoral training at the Hershey Medical Center, Penn State University.